A novel treatment for patients with hereditary haemorrhagic telangiectasia

Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by dermal, mucosal, and visceral telangiectases as well as pulmonary and cerebral arteriovenous malformations. Recurrent epistaxis occurs in the majority of patients, and by the very nature of the thin walle...

Full description

Saved in:
Bibliographic Details
Published in:Journal of laryngology and otology 2002-10, Vol.116 (10), p.849-850
Main Authors: Farnan, T. B., Gallagher, G., Scally, C. M.
Format: Article
Language:English
Subjects:
(RF) Otorhinolaryngology
Aged
Aged, 80 and over
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Epistaxis - etiology
Epistaxis - therapy
Female
Fibrin Tissue Adhesive
Fibrin Tissue Adhesive - therapeutic use
Hereditary Haemorrhagic
Humans
Medical sciences
Non tumoral diseases
Otorhinolaryngology. Stomatology
Telangiectasia
Telangiectasia, Hereditary Hemorrhagic - complications
Tissue Adhesives - therapeutic use
Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by dermal, mucosal, and visceral telangiectases as well as pulmonary and cerebral arteriovenous malformations. Recurrent epistaxis occurs in the majority of patients, and by the very nature of the thin walled vessels involved it is often refractory to conventional forms of treatment. We present the case of an 82-year-old lady with intractable epistaxis secondary to HHT, that was successfully controlled by the application of fibrin glue.
ISSN:0022-2151
1748-5460
DOI:10.1258/00222150260293709